相关实验视频

Updated: May 6, 2026

De Novo Generation of Somatic Stem Cells by YAP/TAZ

De Novo Generation of Somatic Stem Cells by YAP/TAZ

Published on: May 7, 2018

在心肌细胞中YAP/TAZ的影响:一个范围审查

Yenni Limyati^1,2, Ardo Sanjaya^3,4, Ray Sebastian⁵

¹Doctoral Program, Faculty of Medicine, Universitas Padjadjaran, Bandung, West Java, 40164, Indonesia.

Molecular biology reports

|April 15, 2025

概括

河马的路径河马的路径

科学领域:

心血管生物学心血管生物学
分子信号传输的方法
再生医学是一种再生医学.

背景情况:

河马信号通路,涉及对相关蛋白 (YAP) 和具有PDZ结合动机 (TAZ) 的转录协活性剂,对于心脏发育和修复至关重要.
虽然YAP在心肌细胞增殖中的作用已知,但其在心脏生物学中的详细机制需要进一步研究.

研究的目的:

进行范围审查,探索YAP和TAZ在心肌细胞生物学中的机制.
确定YAP/TAZ在心脏再生中的上游调节器,下游途径和治疗潜力.

主要方法:

对使用PRISMA扩展进行范围审查的138项研究进行了选.
根据对心脏再生中的YAP/TAZ信号的相关性,选出文章.
对提取的有关上游调节器,信号通路和治疗应用的数据进行了专题分析.

主要成果:

YAP的激活促进心肌细胞的增殖,分化,以及对氧化应激的保护.
机械传导影响YAP活动,将生物力学与心脏再生联系起来.
确定了新的上游调节器 (前林因受体,黑激素,ERBB2) 和下游通路 (Wnt/β-catenin,PI3K/Akt,TLR介导的炎症).

结论:

YAP/TAZ信号传递是心肌细胞功能和心脏再生的关键调节者.
通过调节YAP来增强心脏修复的已确定治疗点.
突出了研究缺陷,包括TAZ的作用,需要进行体内研究,以及理解复杂的监管网络.

关键词:

心脏肌细胞是心脏肌细胞.心肌损伤是指心肌损伤.肌心脏再生的再生具有PDZ结合动机的转录协活性剂.是的 - 相关蛋白质.

更多相关视频

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...